NM_024426.6:c.1463G>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4BP6BS2_Supporting

The NM_024426.6(WT1):​c.1463G>A​(p.Ser488Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000752 in 1,461,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S488S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

WT1
NM_024426.6 missense

Scores

2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 3.28

Publications

2 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1 Gene-Disease associations (from GenCC):
  • Denys-Drash syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • Wilms tumor 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Frasier syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.35612145).
BP6
Variant 11-32389164-C-T is Benign according to our data. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335. Variant chr11-32389164-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 78335.
BS2
High AC in GnomAdExome4 at 11 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WT1NM_024426.6 linkc.1463G>A p.Ser488Asn missense_variant Exon 10 of 10 ENST00000452863.10 NP_077744.4 P19544-7Q6PI38

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WT1ENST00000452863.10 linkc.1463G>A p.Ser488Asn missense_variant Exon 10 of 10 1 NM_024426.6 ENSP00000415516.5 P19544-7A0A0A0MT54

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000752
AC:
11
AN:
1461818
Hom.:
0
Cov.:
31
AF XY:
0.00000550
AC XY:
4
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33470
American (AMR)
AF:
0.00
AC:
0
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000989
AC:
11
AN:
1111978
Other (OTH)
AF:
0.00
AC:
0
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 Uncertain:1
Oct 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 483 of the WT1 protein (p.Ser483Asn). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with WT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 78335). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt WT1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Benign:1
Mar 11, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
22
DANN
Benign
0.96
Eigen
Benign
-0.16
Eigen_PC
Benign
0.026
FATHMM_MKL
Benign
0.54
D
LIST_S2
Uncertain
0.88
D;.;D;.;.;.;.;.
M_CAP
Benign
0.0066
T
MetaRNN
Benign
0.36
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
3.3
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-1.3
N;N;N;N;N;.;.;.
REVEL
Benign
0.050
Sift
Benign
0.22
T;T;T;T;T;.;.;.
Sift4G
Benign
0.29
T;T;T;T;T;.;.;.
Polyphen
0.0
B;.;.;.;.;.;.;.
Vest4
0.11
MVP
0.32
ClinPred
0.76
D
GERP RS
4.7
gMVP
0.54
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267602849; hg19: chr11-32410710; API